The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
Open accessAbstract
To examine whether weight loss at presentation influences outcome in patients who received chemotherapy for lung cancer or mesothelioma. Multivariate analysis of prospectively collected data 1994-2001. Data were available for age, gender, performance status, histology, stage, response, toxicity, progression-free and overall survival. The outcomes of patients with or without weight loss treated with chemotherapy for small cell lung cancer (SCLC; n=290), stages III and IV non-small-cell lung cancer (NSCLC; n=418), or mesothelioma (n=72) were compared. Weight loss was reported by 59, 58 and 76% of patients with SCLC, NSCLC and mesothelioma, respectively. Patients with weight loss and NSCLC (P=0.003) or mesothelioma (P=0.05) more frequently failed to complete at least three cycles of chemotherapy. Anaemia as a toxicity occurred significantly more frequently in NSCLC patients with weight loss (P=0.0003). The incidence of other toxicities was not significantly affected by weight loss. NSCLC patients with weight loss had fewer symptomatic responses (P=0.001). Mesothelioma patients with weight loss had fewer symptomatic (P=0.03) and objective responses (P=0.05). Weight loss was an independent predictor of shorter overall survival for patients with SCLC (P=0.003, relative risk (RR)=1.5), NSCLC (P=0.009, RR=1.33) and mesothelioma (P=0.03, RR=1.92) and an independent predictor of progression-free survival in patients with SCLC (P=0.01, RR=1.43). In conclusion, weight loss as a symptom of lung cancer predicts for toxicity from treatment and shorter survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285 · cited 2×
“Objective response to treatment was classified using the WHO/ UICC response criteria following serial CT scans every 6 weeks and chest X-rays every 3 weeks (WHO, 1979).”
MethodPrognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
WHO Handbook for Reporting Results of Cancer Treatment
Palmer, M. K. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.83 · Cited by 2,198
Kelly, K., Crowley, J., Bunn, P. A., Presant, C. A., Grevstad, P. K., Moinpour, C. M., Ramsey, S. D., Wozniak, A. J., Weiss, G. R., Moore, D. F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3210 · Cited by 1,123
Elderly Lung Cancer Vinorelbine Italian Study Group (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.66 · Cited by 869
Bonomi, P., Kim, K., Fairclough, D., Cella, D., Kugler, J., Rowinsky, E., Jiroutek, M., & Johnson, D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.623 · Cited by 589
Continuing increase in mesothelioma mortality in Britain
Peto, J., Matthews, F. E., Hodgson, J. T., & Jones, J. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90462-x · Cited by 568
Prognostic Factors for Survival in Patients With Inoperable Lung Cancer 2
(1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/65.1.25 · Cited by 564
Curran, D., Sahmoud, T., Therasse, P., van Meerbeeck, J., Postmus, P. E., & Giaccone, G. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.145 · Cited by 543
Herndon, J. E., Green, M. R., Chahinian, A. P., Corson, J. M., Suzuki, Y., & Vogelzang, N. J. (1998) · Chest · doi:10.1378/chest.113.3.723 · Cited by 504
Cullen, M. H., Billingham, L. J., Woodroffe, C. M., Chetiyawardana, A. D., Gower, N. H., Joshi, R., Ferry, D. R., Rudd, R. M., Spiro, S. G., Cook, J. E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3188 · Cited by 445
Paesmans, M., Sculier, J. P., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Van Cutsem, O., Sergysels, R., & Mommen, P. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1221 · Cited by 386
Edwards, J. G. (2000) · Thorax · doi:10.1136/thorax.55.9.731 · Cited by 324
Smith, I. E., O’Brien, M. E. R., Talbot, D. C., Nicolson, M. C., Mansi, J. L., Hickish, T. F., Norton, A., & Ashley, S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1336 · Cited by 308
Self-citationOvesen, L., Allingstrup, L., Hannibal, J., Mortensen, E. L., & Hansen, O. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2043 · Cited by 271
Total parenteral nutrition and cancer clinical trials
Klein, S., Simes, R. J., & Blackburn, G. L. (1986) · Cancer · doi:10.1002/1097-0142(19860915)58:6<1378::aid-cncr2820580635>3.0.co;2-s · Cited by 245
O'Connell, J. P., Kris, M. G., Gralla, R. J., Groshen, S., Trust, A., Fiore, J. J., Kelsen, D. P., Heelan, R. T., & Golbey, R. B. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.11.1604 · Cited by 238
Staal-van den Brekel, A. J., Dentener, M. A., Schols, A. M., Buurman, W. A., & Wouters, E. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2600 · Cited by 218
Evans, W. K., Nixon, D. W., Daly, J. M., Ellenberg, S. S., Gardner, L., Wolfe, E., Shepherd, F. A., Feld, R., Gralla, R., & Fine, S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.113 · Cited by 186
Bremnes, R. M., Sundstrom, S., Aasebø, U., Kaasa, S., Hatlevoll, R., & Aamdal, S. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00508-1 · Cited by 186
Elevated energy expenditure in cancer patients with solid tumours
Hyltander, A., Drott, C., Körner, U., Sandström, R., & Lundholm, K. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90050-n · Cited by 158
Simons, J., Schols, A. M. W. J., Buurman, W. A., & Wouters, E. F. �. (1999) · Clinical Science · doi:10.1042/cs0970215 · Cited by 156
Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis.
McGeer, A., Detsky, A. S., & O'Rourke, K. (1990) · PubMed · Cited by 142
Impact of patient weight on non-relapse mortality after marrow transplantation.
Deeg, H. J., Seidel, K. D., Bruemmer, B., Pepe, M., & Appelbaum, F. R. (1995) · PubMed · Cited by 139
Analysis of the energy balance in lung cancer patients
den Brekel, A. J. S.-V. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)98799-g · Cited by 70
Clinical Factors and Prognosis in Non–Small Cell Lung Cancer
Martins, S. J., & Pereira, J. R. (1999) · American Journal of Clinical Oncology · doi:10.1097/00000421-199910000-00006 · Cited by 68
Resting energy expenditure in patients with non-small cell lung cancer
Fredrix, E. W. H. M., Wouters, E. F. �., Soeters, P. B., Aalst, A. C. M. J. V. D., Kester, A. D. M., MEYENFELDT, M. F. V., & Saris, W. H. M. (1991) · Cancer · doi:10.1002/1097-0142(19911001)68:7<1616::aid-cncr2820680725>3.0.co;2-3 · Cited by 51
Tas, A. A. F. F. (1999) · Acta Oncologica · doi:10.1080/028418699432275 · Cited by 50
Ray, P., Quantin, X., Grenier, J., & Pujol, J.-L. (1998) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1998.cdoa43.x · Cited by 47
The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer
Jatoi, A., Daly, B. D. T., HUGHES, V. A., Dallal, G. E., & Roubenoff, R. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00008-2 · Cited by 26
Jones, A. L., Holborn, J., Ashley, S. E., & Smith, I. E. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90136-2 · Cited by 7
Self-citation
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
ESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
“Indeed weight stabilization for patients with GI and lung cancers is correlatedwith significant improvements in survival [106,107].”
BackgroundTisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
ESPEN practical guideline: Clinical nutrition in surgery
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R. G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.031 · Cited by 1,173
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K., Arends, J., & Baracos, V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 940
Metadata
- Authors
- Ross, P. J., Ashley, S., Norton, A., Priest, K., Waters, J. S., Eisen, T., Smith, I. E., & O'Brien, M. E. R.
- Venue
- British Journal of Cancer
- Published
- 2004-04-20
- Volume
- 90
- Issue
- 10
- Pages
- 1905-1911
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2046387692
- Cited by
- 476
- References
- 34
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.